Medicamen Organics Profile
Key Indicators
- Authorised Capital ₹ 14.00 Cr
as on 30-07-2024
- Paid Up Capital ₹ 8.60 Cr
as on 30-07-2024
- Company Age 29 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.27 Cr
as on 30-07-2024
- Satisfied Charges ₹ 17.34 Cr
as on 30-07-2024
- Revenue 8.38%
(FY 2023)
- Profit 1499.74%
(FY 2023)
- Ebitda 57.95%
(FY 2023)
- Net Worth 16.36%
(FY 2023)
- Total Assets 17.46%
(FY 2023)
About Medicamen Organics
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 14.00 Cr and a paid-up capital of Rs 8.60 Cr.
The company currently has active open charges totaling ₹8.27 Cr. The company has closed loans amounting to ₹17.34 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Medicamen Organics Limited. India are Varsha Bansal as COMPANY SECRETARY and Lalit Gupta as Cfo. Bal Gupta, Ashutosh Gupta, Rajinder Gupta, and Four other members serve as directors at the Company.
- CIN/LLPIN
U74899DL1995PLC066416
- Company No.
066416
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
15 Mar 1995
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Medicamen Organics?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bal Gupta  | Managing Director | 15-Mar-1995 | Current |
| Varsha Bansal | Company Secretary | 04-Jan-2024 | Current |
| Lalit Gupta | CFO | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ashutosh Gupta | Whole-Time Director | 01-Apr-2004 | Current |
| Rajinder Gupta | Director | Current | |
| Shailesh Gaur | Director | 21-Jan-2020 | Current |
| Sneh Gaur | Director | Current | |
| Sachin Gupta | Director | Current | |
| Rakesh Kumar | Director | Current |
Financial Performance of Medicamen Organics.
Medicamen Organics Limited., for the financial year ended 2023, experienced modest growth in revenue, with a 8.38% increase. The company also saw a substantial improvement in profitability, with a 1499.74% increase in profit. The company's net worth Soared by an impressive increase of 16.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medicamen Organics?
In 2023, Medicamen Organics had a promoter holding of 85.10% and a public holding of 14.90%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Redline Health Care Private LimitedActive 9 years 7 months
Bal Gupta and Ashutosh Gupta are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 26 Jun 2024 | ₹1.58 M | Open |
Axis Bank Limited Creation Date: 15 Mar 2024 | ₹1.70 M | Open |
Axis Bank Limited Creation Date: 07 Jul 2021 | ₹2.87 M | Open |
How Many Employees Work at Medicamen Organics?
Medicamen Organics has a workforce of 45 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medicamen Organics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medicamen Organics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
